AEGIS CAPITAL CORP.
CRD #15007 SEC #801-71386 NEW YORK, NY 212-813-1010
SEC Registered Broker-Dealer Private Funds Disclosures
Total AUM
$1.4B
Discretionary
$631.9M
Employees
270
Clients
26
Accounts
2,760
| Fund Name | Type | GAV | Investors | Auditor |
|---|---|---|---|---|
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II | Private Equity Fund | $19.5M | 53 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II | Private Equity Fund | $19.5M | 53 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II | Private Equity Fund | $19.5M | 53 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH V | Private Equity Fund | $14.8M | 69 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH V | Private Equity Fund | $14.8M | 69 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH V | Private Equity Fund | $14.8M | 69 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE III | Private Equity Fund | $13.7M | 91 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE III | Private Equity Fund | $13.7M | 91 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE III | Private Equity Fund | $13.7M | 91 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IV | Private Equity Fund | $12.3M | 97 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IV | Private Equity Fund | $12.3M | 97 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IV | Private Equity Fund | $12.3M | 97 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IX | Private Equity Fund | $9.7M | 73 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IX | Private Equity Fund | $9.7M | 73 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IX | Private Equity Fund | $9.7M | 73 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH III | Private Equity Fund | $7.5M | 65 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH III | Private Equity Fund | $7.5M | 65 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH III | Private Equity Fund | $7.5M | 65 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII | Private Equity Fund | $7M | 31 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII | Private Equity Fund | $7M | 31 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII | Private Equity Fund | $7M | 31 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE II | Private Equity Fund | $7M | 64 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE II | Private Equity Fund | $7M | 64 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE II | Private Equity Fund | $7M | 64 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X | Private Equity Fund | $6.2M | 51 | CITRIN COOPERMAN & COMPANY, LLP |
TypePrivate Equity Fund
GAV$19.5M
Investors53
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$19.5M
Investors53
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$19.5M
Investors53
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$14.8M
Investors69
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$14.8M
Investors69
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$14.8M
Investors69
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$13.7M
Investors91
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$13.7M
Investors91
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$13.7M
Investors91
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$12.3M
Investors97
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$12.3M
Investors97
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$12.3M
Investors97
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$9.7M
Investors73
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$9.7M
Investors73
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$9.7M
Investors73
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7.5M
Investors65
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7.5M
Investors65
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7.5M
Investors65
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7M
Investors31
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7M
Investors31
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7M
Investors31
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7M
Investors64
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7M
Investors64
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$7M
Investors64
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$6.2M
Investors51
AuditorCITRIN COOPERMAN & COMPANY, LLP